Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.0045 | 1 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |